...
首页> 外文期刊>British Journal of Cancer >Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers
【24h】

Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers

机译:I1307K APC突变与遗传性和散发性乳腺癌/卵巢癌的关联:问题多于答案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The frequency of the APC I1307K mutation and its association with disease pattern was examined in 996 Ashkenazi women consisting of individuals with either sporadic (n = 382) or hereditary (n = 143) breast and/or ovarian cancer; asymptomatic BRCA1/2 mutation carriers (185delAG, 5382insC and 6174delT) (n = 53) and healthy controls (n = 418). The I1307K allele was equally distributed among women with sporadic (17/382; 4.6%) and inherited (10/143; 7%) breast and/or ovarian cancer irrespective of their being diagnosed before or after 42 years of age and among asymptomatic (7/53; 13.2%) and cancer manifesting BRCA1/2 carriers (10/143; 7%). Taken together, the prevalence of the I1307K allele was significantly higher in BRCA1/2 carriers compared to non-BRCA1/2 carriers (17/196; 8.7% and 40/800, 5%; respectively). The high prevalence of the I1307K allele among BRCA1/2 carriers is not associated with increased cancer risk but seems to be genetically connected because of Jewish ancestry. ? 2000 Cancer Research Campaign
机译:在996名Ashkenazi妇女中检查了APC I1307K突变的频率及其与疾病模式的关系,这些妇女由患有散发性(n = 382)或遗传性(n = 143)乳腺癌和/或卵巢癌的个体组成;无症状的BRCA1 / 2突变携带者(185delAG,5382insC和6174delT)(n = 53)和健康对照(n = 418)。 I1307K等位基因在散发性乳腺癌和/或卵巢癌的女性中平均分布(17/382; 4.6%),并且在遗传性乳腺癌和/或卵巢癌中(10/143; 7%),无论在42岁之前或之后被诊断为无症状(7/53; 13.2%)和表现为BRCA1 / 2携带者的癌症(10/143; 7%)。两者合计,与非BRCA1 / 2携带者相比,BRCA1 / 2携带者中I1307K等位基因的患病率显着更高(分别为17/196; 8.7%和40 / 800、5%)。在BRCA1 / 2携带者中I1307K等位基因的高流行与增加的癌症风险无关,但由于犹太血统,似乎与遗传相关。 ? 2000年癌症研究运动

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号